Enterprise HL7 / FHIR Terminology Engine
Universal Clinical Codes & Terminology Search
Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.
Showing 20 of 23669 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
| Code Value | Display Description | Code System & OID | FHIR Resource | Category | Status | Actions |
|---|---|---|---|---|---|---|
|
Q0520
|
Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug per 60-days
|
HCPCS
2.16.840.1.113883.6.14
|
Procedures | Procedures | Active |
|
|
Q0521
|
Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription
|
HCPCS
2.16.840.1.113883.6.14
|
Procedures | Procedures | Active |
|
|
Q14
|
Congenital malformations of posterior segment of eye
|
ICD-10-CM
2.16.840.1.113883.6.90
|
Condition | Congenital malformations of eye, ear, face and neck | Active |
|
|
Q14.8
|
Other congenital malformations of posterior segment of eye
|
ICD-10-CM
2.16.840.1.113883.6.90
|
Condition | Congenital malformations of eye, ear, face and neck | Active |
|
|
Q14.9
|
Congenital malformation of posterior segment of eye unspecified
|
ICD-10-CM
2.16.840.1.113883.6.90
|
Condition | Congenital malformations of eye, ear, face and neck | Active |
|
|
Q2017
|
Injection teniposide 50 mg
|
HCPCS
2.16.840.1.113883.6.14
|
Procedures | Procedures | Active |
|
|
Q2040
|
Tisagenlecleucel up to 250 million car-positive viable t cells including leukapheresis and dose preparation procedures per infusion
|
HCPCS
2.16.840.1.113883.6.14
|
Procedures | Procedures | Active |
|
|
Q2041
|
Axicabtagene ciloleucel up to 200 million autologous anti-cd19 car positive viable t cells including leukapheresis and dose preparation procedures per therapeutic dose
|
HCPCS
2.16.840.1.113883.6.14
|
Procedures | Procedures | Active |
|
|
Q2042
|
Tisagenlecleucel up to 600 million car-positive viable t cells including leukapheresis and dose preparation procedures per therapeutic dose
|
HCPCS
2.16.840.1.113883.6.14
|
Procedures | Procedures | Active |
|
|
Q2049
|
Injection doxorubicin hydrochloride liposomal imported lipodox 10 mg
|
HCPCS
2.16.840.1.113883.6.14
|
Procedures | Procedures | Active |
|
|
Q2050
|
Injection doxorubicin hydrochloride liposomal not otherwise specified 10 mg
|
HCPCS
2.16.840.1.113883.6.14
|
Procedures | Procedures | Active |
|
|
Q2053
|
Brexucabtagene autoleucel up to 200 million autologous anti-cd19 car positive viable t cells including leukapheresis and dose preparation procedures per therapeutic dose
|
HCPCS
2.16.840.1.113883.6.14
|
Procedures | Procedures | Active |
|
|
Q2054
|
Lisocabtagene maraleucel up to 110 million autologous anti-cd19 car-positive viable t cells including leukapheresis and dose preparation procedures per therapeutic dose
|
HCPCS
2.16.840.1.113883.6.14
|
Procedures | Procedures | Active |
|
|
Q2055
|
Idecabtagene vicleucel up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells including leukapheresis and dose preparation procedures per therapeutic dose
|
HCPCS
2.16.840.1.113883.6.14
|
Procedures | Procedures | Active |
|
|
Q2056
|
Ciltacabtagene autoleucel up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells including leukapheresis and dose preparation procedures per therapeutic dose
|
HCPCS
2.16.840.1.113883.6.14
|
Procedures | Procedures | Active |
|
|
Q2058
|
Obecabtagene autoleucel 10 up to 400 million cd19 car-positive viable t cells including leukapheresis and dose preparation procedures per infusion
|
HCPCS
2.16.840.1.113883.6.14
|
Procedures | Procedures | Active |
|
|
Q54
|
Hypospadias
|
ICD-10-CM
2.16.840.1.113883.6.90
|
Condition | Congenital malformations of genital organs | Active |
|
|
Q54.0
|
Hypospadias balanic
|
ICD-10-CM
2.16.840.1.113883.6.90
|
Condition | Congenital malformations of genital organs | Active |
|
|
Q54.1
|
Hypospadias penile
|
ICD-10-CM
2.16.840.1.113883.6.90
|
Condition | Congenital malformations of genital organs | Active |
|
|
Q54.2
|
Hypospadias penoscrotal
|
ICD-10-CM
2.16.840.1.113883.6.90
|
Condition | Congenital malformations of genital organs | Active |
|
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD
In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside
Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.
An OID is an internationally standardized dotted-decimal identifier (e.g.
2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.
Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.